Benz Advisory
Share:
Subscribe:
news.cision.com
/
Benz Advisory
/
Muvon Therapeutics announces First Patient Enrolled in Phase II Clinical Study in Female Patients with Stress Urinary Incontinence using Novel Regenerative Cell Therapy
/
3656315_0.jpeg
3656315_0.jpeg
Thu, Oct 27, 2022 09:09 CET
Low resolution
Medium resolution
Original resolution
Subscribe
